These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22322105)

  • 21. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.
    Varon D; Barker W; Loewenstein D; Greig M; Bohorquez A; Santos I; Shen Q; Harper M; Vallejo-Luces T; Duara R;
    Int J Geriatr Psychiatry; 2015 Feb; 30(2):192-200. PubMed ID: 24816477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
    Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
    Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition.
    Leow AD; Yanovsky I; Parikshak N; Hua X; Lee S; Toga AW; Jack CR; Bernstein MA; Britson PJ; Gunter JL; Ward CP; Borowski B; Shaw LM; Trojanowski JQ; Fleisher AS; Harvey D; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Neuroimage; 2009 Apr; 45(3):645-55. PubMed ID: 19280686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
    Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Network Structure of Depressive Symptomatology in Elderly with Cognitive Impairment.
    Pyo J; Lee H; Lee J; Lee D; Yu H; Lim SW; Myung W; Kim DK
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792870
    [No Abstract]   [Full Text] [Related]  

  • 27. Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M; Egger K; Marksteiner J; Esterhammer R; Hinterhuber H; Deisenhammer EA; Schocke M
    PLoS One; 2014; 9(8):e106062. PubMed ID: 25153085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD.
    Spulber G; Niskanen E; Macdonald S; Kivipelto M; Padilla DF; Julkunen V; Hallikainen M; Vanninen R; Wahlund LO; Soininen H
    Curr Alzheimer Res; 2012 May; 9(4):516-24. PubMed ID: 22191564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic Resonance Imaging in Stable Mild Cognitive Impairment, Prodromal Alzheimer's Disease, and Prodromal Dementia with Lewy Bodies.
    Siddiqui TG; Whitfield T; Praharaju SJ; Sadiq D; Kazmi H; Ben-Joseph A; Walker Z
    Dement Geriatr Cogn Disord; 2020; 49(6):583-588. PubMed ID: 33227783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grey matter atrophy in mild cognitive impairment / early Alzheimer disease associated with delusions: a voxel-based morphometry study.
    Ting WK; Fischer CE; Millikin CP; Ismail Z; Chow TW; Schweizer TA
    Curr Alzheimer Res; 2015; 12(2):165-72. PubMed ID: 25654501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional signature of conversion of patients with mild cognitive impairment.
    Delli Pizzi S; Punzi M; Sensi SL;
    Neurobiol Aging; 2019 Feb; 74():21-37. PubMed ID: 30408719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Martinez-Torteya A; Gomez-Rueda H; Trevino V; Farber J; Tamez-Pena J; For The Alzheimer's Disease Neuroimaging Initiative
    Curr Alzheimer Res; 2018; 15(8):751-763. PubMed ID: 29422002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Defrancesco M; Marksteiner J; Kemmler G; Fleischhacker WW; Blasko I; Deisenhammer EA
    J Alzheimers Dis; 2017; 59(4):1439-1448. PubMed ID: 28731429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
    Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
    Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression.
    Censi S; Sestieri C; Punzi M; Delli Pizzi A; Ferretti A; Gambi F; Tomassini V; Delli Pizzi S; Sensi SL
    J Prev Alzheimers Dis; 2024; 11(4):1030-1040. PubMed ID: 39044514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
    Whitwell JL; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
    Brain; 2007 Jul; 130(Pt 7):1777-86. PubMed ID: 17533169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
    Brendel M; Pogarell O; Xiong G; Delker A; Bartenstein P; Rominger A;
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):716-24. PubMed ID: 25631614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis.
    Ding X; Yin L; Zhang L; Zhang Y; Zha T; Zhang W; Gui B;
    Alzheimers Dement; 2024 Jul; 20(7):4583-4593. PubMed ID: 38865281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.